Annai Jin Pian (安乃近片)安乃近片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
批准文号:NMPA approval number: 国药准字H41021280
生产企业Manufacturer
- 河南省安阳市第一制药厂Chinese legal name: 河南省安阳市第一制药厂
药物知识说明
国药准字H41021280是一种在国家药监局注册认定的药品。标注生产企业为河南省安阳市第一制药厂。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：河南省安阳市第一制药厂Chinese legal name: 河南省安阳市第一制药厂、河南省安阳市第一制药厂Chinese legal name: 河南省安阳市第一制药厂、河南省安阳市第一制药厂Chinese legal name: 河南省安阳市第一制药厂。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 安乃近片) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 河南省安阳市第一制药厂.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 河南省安阳市第一制药厂Chinese legal name: 河南省安阳市第一制药厂, 河南省安阳市第一制药厂Chinese legal name: 河南省安阳市第一制药厂, 河南省安阳市第一制药厂Chinese legal name: 河南省安阳市第一制药厂.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 安乃近片Recorded Chinese name: 安乃近片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 0.5g0.5 g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 河南省安阳市第一制药厂Chinese legal name: 河南省安阳市第一制药厂
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H41021280
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H41021280
Manufacturer
Chinese legal name: 河南省安阳市第一制药厂 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H41021280
生产企业
河南省安阳市第一制药厂(国产)
适应症
本品用于高热时的解热，也可用于头痛、偏头痛、肌肉痛、关节痛、痛经等。本品亦有较强的抗风湿作用，可用于急性风湿性关节炎，但因本品有可能引起严重的不良反应，很少在风湿性疾病中应用。
用法用量
口服。 1.成人常用量：一次0.5～1g，需要时服1次，最多一日3次。 2.小儿：按体重一次10～20mg/kg，一日2～3次。
不良反应
本品对胃肠道的刺激虽较小，但可引起以下各种不良反应:
1.血液方面，可引起粒细胞缺乏症，发生率约1.1%，急性起病，重者有致命危险，亦可引起自身免疫性溶血性贫血、血小板减少性紫癜、再生障碍性贫血等。
2.皮肤方面，可引起荨麻疹、渗出性红斑等过敏性表现，严重者可发生剥脱性皮炎、表皮松解症等。
3.个别病例可发生过敏性休克，甚至导致死亡。对本品或氨基比林有过敏史者禁用。
禁忌
对本品或氨基比林有过敏史者禁用。
注意事项
1.本品与阿司匹林有交叉过敏反应。
2.本品一般不作首选用药，仅在急性高热、病情急重，又无其他有效解热药可用的情况下用于紧急退热。
3.本品用药超过1周时应定期检查血象，一旦发生粒细胞减少，应立即停药。
贮藏
遮光，密封保存。
规格
0.5g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.